4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-24-000061
President and CEO sold 9,589 shares at $17.29 ($165,794)
From the SEC's structured data for this filing
Trades in this filing
Watts Ryan J. · President and CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-02-13 | Sale : show line 1 in the form | −9,589 | $17.29 | $165,794 | 238,067 | D |
| Open-market sales · 9,589 sh · avg $17.29 · $165,794 | ||||||
Loading xslF345X05/wk-form4_1708049710.xml…